1. Home
  2. CRBU vs SRI Comparison

CRBU vs SRI Comparison

Compare CRBU & SRI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CRBU
  • SRI
  • Stock Information
  • Founded
  • CRBU 2011
  • SRI 1965
  • Country
  • CRBU United States
  • SRI United States
  • Employees
  • CRBU N/A
  • SRI N/A
  • Industry
  • CRBU Medicinal Chemicals and Botanical Products
  • SRI Auto Parts:O.E.M.
  • Sector
  • CRBU Health Care
  • SRI Consumer Discretionary
  • Exchange
  • CRBU Nasdaq
  • SRI Nasdaq
  • Market Cap
  • CRBU 93.0M
  • SRI 106.8M
  • IPO Year
  • CRBU 2021
  • SRI 1997
  • Fundamental
  • Price
  • CRBU $0.74
  • SRI $3.78
  • Analyst Decision
  • CRBU Strong Buy
  • SRI Buy
  • Analyst Count
  • CRBU 5
  • SRI 2
  • Target Price
  • CRBU $11.80
  • SRI $16.00
  • AVG Volume (30 Days)
  • CRBU 1.1M
  • SRI 258.9K
  • Earning Date
  • CRBU 05-06-2025
  • SRI 04-30-2025
  • Dividend Yield
  • CRBU N/A
  • SRI N/A
  • EPS Growth
  • CRBU N/A
  • SRI N/A
  • EPS
  • CRBU N/A
  • SRI N/A
  • Revenue
  • CRBU $9,994,000.00
  • SRI $908,295,000.00
  • Revenue This Year
  • CRBU N/A
  • SRI N/A
  • Revenue Next Year
  • CRBU $163.34
  • SRI $10.21
  • P/E Ratio
  • CRBU N/A
  • SRI N/A
  • Revenue Growth
  • CRBU N/A
  • SRI N/A
  • 52 Week Low
  • CRBU $0.66
  • SRI $3.54
  • 52 Week High
  • CRBU $4.21
  • SRI $18.40
  • Technical
  • Relative Strength Index (RSI)
  • CRBU 34.01
  • SRI 37.91
  • Support Level
  • CRBU $0.71
  • SRI $3.69
  • Resistance Level
  • CRBU $0.94
  • SRI $3.92
  • Average True Range (ATR)
  • CRBU 0.10
  • SRI 0.35
  • MACD
  • CRBU 0.00
  • SRI -0.05
  • Stochastic Oscillator
  • CRBU 23.44
  • SRI 19.20

About CRBU Caribou Biosciences Inc.

Caribou Biosciences Inc is a clinical-stage Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR) biopharmaceutical company dedicated to transforming the lives of patients with devastating diseases by applying its novel CRISPR platform, CRISPR hybrid RNA-DNA (chRDNA), toward the development of next-generation, genome-edited cell therapies. The company operates and manage business as one reportable operating segment, which is the business of developing a pipeline of allogeneic CAR-T and CAR-NK cell therapies. Geographically, it operates in United States and Rest of the World, of which United States derives maximum revenue.

About SRI Stoneridge Inc.

Stoneridge Inc is a manufacturer of electrical and electronic components used in automotive vehicles. The company produces instrumentation systems, vehicle management electronics, application-specific switches and actuators, sensors, security alarms, and vehicle tracking devices and monitoring services for commercial, automotive, off-highway, and agricultural vehicle markets. Stoneridge generates the majority of its revenue in its Electronics segment that produces driver information systems, camera-based vision systems, connectivity, and compliance products, and electronic control units. Geographically, the company's operations are focused on North America. It has Control Devices, Electronics, and Stoneridge Brazil segments.

Share on Social Networks: